Clinical Trial Update: Cellular Adoptive Immunotherapy in Treating Patients With Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

This clinical trial update summarizes a completed Phase 2 study examining cellular adoptive immunotherapy in patients with glioblastoma multiforme.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Cellular Adoptive Immunotherapy

Snippet

Sponsor: Hoag Memorial Hospital Presbyterian | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED